XBiotech Inc. (XBIT) Return on equity 2018–2023
XBiotech Inc. (XBIT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-11.2%FY2023 · since FY2018: -51.1% → -11.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -11.2% | +2.5 pp |
| FY2022 | -13.7% | -7.2 pp |
| FY2021 | -6.5% | -3.2 pp |
| FY2020 | -3.2% | -91.7 pp |
| FY2019 | 88.5% | +139.5 pp |
| FY2018 | -51.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIT financial trends
XBIT RevenueXBIT Net incomeXBIT Net marginXBIT Gross profitXBIT Gross marginXBIT Operating incomeXBIT Operating marginXBIT Operating cash flowXBIT Free cash flowXBIT Capital expendituresXBIT Stock buybacksXBIT Dividends paidXBIT Total assetsXBIT Total liabilitiesXBIT Shareholders’ equityXBIT overview →